谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Neoadjuvant Dynamic Marker-Adjusted Personalized Therapy Comparing Trastuzumab-Deruxtecan Versus Pacli-/Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in HER2+ Early Breast Cancer: WSG-ADAPT-HER2-IV.

Nadia Harbeck,Michael Braun,Oleg Gluz,Peter Schmid,Monika Karla Graeser,Andreas D. Hartkopf,Oliver Hoffmann,Athina Kostara,Silke Polata,Lea Louise Volmer,Raquel von Schumann,Sarah Wetzig,Stefanie Wiebe, Matthias R. Zaiss,Lotta Ada Fischer,Iris Scheffen,Matthias Christgen,Hans Heinrich Kreipe,Ulrike Nitz,Sherko Kuemmel

Journal of Clinical Oncology（2024）

引用 0|浏览22
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要